Assessing the likely harms to kidney vendors in regulated organ markets.
about
From blood donation to kidney sales: the gift relationship and transplant commercialism.Kamakahi vs ASRM and the future of compensation for human eggs.Organ markets: problems beyond harms to vendors.The Body as Gift, Commodity, or Something in Between: Ethical Implications of Advanced Kidney Donation.Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Beyond Fair Benefits: Reconsidering Exploitation Arguments Against Organ Markets.Does the ethical appropriateness of paying donors depend on what body parts they donate?Kidney Sales and Market Regulation: A Reply to Semrau.Are kidney markets morally permissible if vendors do not benefit?Avoiding Harms to Kidney Vendors through Legal, Regulated MarketsThe Truth About IranAll the More Reason: Why Julian Koplin Should Support a Trial of Incentives for Organ DonationRegulated Markets of Kidneys in Developed Countries or How to Increase Health InequitiesHarms to Vendors: We Should Discourage, Not Prohibit Organ SalesMistakes and KidneysRegulated Organ Market: Reality Versus RhetoricRisk, Regulation, and Financial Incentives for Living Kidney DonationPlaying Into the Hands of the Promarket CampaignersA Fuller Picture of Organ MarketsPaid Living Kidney Transplantation in Iran: Rethinking the ChallengesA Closer Look at the Iranian Model of Kidney TransplantationA Further Lesson From Existing Kidney MarketsSelling Ourselves: The Ethics of Paid Living Kidney Donation
P2860
Q34497735-121E118C-D0A3-4C2C-BE91-2DC4AE830600Q36354447-987CA7F2-931C-4CD7-972A-CABF2C3CC258Q44444781-DFB38876-722B-4A1E-8C68-2759895ACD1FQ46134729-A2CDCB4D-2D3A-4D01-8BF5-A2E9C203398DQ47578488-EF1FD8EE-64D3-41CA-9A3E-F2B4C33BB5D7Q48276551-89AA9EB3-D73F-4753-8E3C-D4C3F3939E02Q48822438-F5453140-653F-4DB3-899B-0A12BF5C7920Q49921623-0497E1F1-6277-4BC7-B059-48F97099EBF5Q53259702-3E09C988-F122-4537-B04E-2C552122BA44Q57988367-268FA411-B9F9-41AE-95F1-97324A0465ACQ57988423-A1FEAEFE-18FD-414D-880E-6388AE365004Q57988717-928A9BFF-387E-4BBD-AB45-BF25E86543EBQ57988771-F0731604-C607-4940-9760-C20E0F33A27BQ57988856-838E82BD-36BA-4D83-A004-BE98CB443A74Q57988874-FA287C48-A338-4F2C-8FAD-F1A61D2703B7Q57988886-A0E3114A-AC40-476F-A4FE-5C90BC5F4FB8Q57988903-A7546FC1-D0D0-4A78-8183-72815E46E14EQ57988909-639F9645-891D-498E-B9D4-DC153AF764FEQ57988987-E1482A71-3C03-49C0-9B2F-F6935EF96077Q57989315-C89DBDE4-6170-4048-B28D-C82C6D3E9B24Q57989486-35BC71E3-AD2E-42D0-B69E-281C6C36D60FQ57989549-CF310405-E49C-46C5-B000-B169BE88E07EQ57989923-0FF10D05-EF5B-4C76-A023-B17C1AF24330
P2860
Assessing the likely harms to kidney vendors in regulated organ markets.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Assessing the likely harms to kidney vendors in regulated organ markets.
@en
type
label
Assessing the likely harms to kidney vendors in regulated organ markets.
@en
prefLabel
Assessing the likely harms to kidney vendors in regulated organ markets.
@en
P2860
P1476
Assessing the likely harms to kidney vendors in regulated organ markets.
@en
P2093
Julian Koplin
P2860
P356
10.1080/15265161.2014.947041
P577
2014-01-01T00:00:00Z